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Microwave-assisted synthesisa b s t r a c t
A convenient and efﬁcient methodology for the synthesis of new C-3 sulfur-substituted indoles under
CeCl37H2O promotion is reported. Model bis(indol-3-yl)sulﬁde 4a and bis(indol-3-yl)sulfone 5a proved
to display potent antioxidant activity at the low micromolar level, in DPPH, ABTS, and FRAP assays, as
well as in the inhibition of the peroxidation of linoleic acid.
 2013 Elsevier Ltd. All rights reserved.6Introduction
Involvement of oxidative stress in the pathogenesis of various
disorders and diseases is well documented.1 Oxidative stress takes
place when the production of reactive oxygen species (ROS), such
as superoxide radical (O2), H2O2, singlet oxygen (1O2) and peroxyl
radical (ROO), exceeds the capacity of the cellular antioxidant de-
fenses to remove these toxic agents.1c ROS can attack membrane
lipids, proteins, and nucleic acids, disrupting normal cell
physiology.1c
Antioxidant pharmacotherapy has emerged as a tool to mini-
mize the biomolecular damage caused by the attack of ROS to these
vital constituents of living organisms,1a and therefore synthetic
antioxidants have received much attention from the pharmaceuti-
cal viewpoint.1 Interestingly, a signiﬁcant number of research
groups have focused on the role of sulfur- and selenium-containing
compounds as antioxidants.2
The indole scaffold is widely found among natural products and
synthetic compounds, which exhibit a range of important biologi-
cal activities.3 Many indole derivatives have been synthesized in
search of new antioxidants.4 Different functional groups and het-
erocyclic moieties attached to the indole nucleus have been shown
to modulate the antioxidant ability of the resulting compounds,5
and the nature of the C-3 functionalization is regarded as relevantfor good potency. Therefore, a facile access to these derivatives
seems important. One of the most widely used protocols toward
C-3 substituted indoles involves the Lewis or protic acid-promoted
electrophilic substitution reaction.7
In view of our interest in the development of new and cleaner
alternative methods for classical reactions, promoted by ceriu-
m(III) species,8 and with the aim of preparing new and bioactive
indoles, we decided to study the direct electrophilic substitution
reaction of indoles at the C-3 position with aromatic sulfonothio-
ates9 and investigate the antioxidant activity of the resulting sul-
fur-containing compounds (Scheme 1).
Results and discussion
In preliminary experiments, the best reaction conditions were
established by the use of indole (1a, R1 = R2 = H, 1.0 mmol) and
p-toluene sulfonothioate (2a, R3 = Me, 1.0 mmol) as starting mate-
rials. We examined the effect of the solvent [DMF, N,N0-dimethyl-
acetamide (DMA), 2-propanol, MeCN, and MeNO2], temperature
(70–100 C), and amount of CeCl37H2O [0.5–1.0 equiv] as the
promoter.
The results revealed that all three variables affected the reac-
tion, being the use 1.0 equiv of CeCl37H2O in DMF at 80 C the
conditions furnishing the best performance (98%; Table 1, entry
1). A decrease in the yield was observed when the transformation
was carried out at 70 C (81%), while at 110 C the presence of bi-
s(indol-3-yl)sulﬁde (4a) was detected by GC–MS in the crude
reaction mixture and the yield of 3a was signiﬁcantly lower
(49%).
Table 2









R1= H, Br, 4-Me-C6H4
R2= H, Me









Entry R1 R2 Product Yieldb (%)
1 H H 4a 89
2 H Me 4b 86
3 Br H 4c 78
4 4-Me–C6H4 H 4d 70
a The reactions were carried out with the indoles (1, 2.0 mmol), p-toluene sul-
fonothioate (2a, 1.0 mmol) and CeCl37H2O (2.0 mmol) in DMA (4.0 mL), under
microwave irradiation (160 C, 100 W) for 20 min.
b Isolated yield. All products were characterized by GC–MS, 1H and 13C NMR, and
elemental analysis.
Table 3









R1= H, Br, 4-Me-C6H4







Entry R1 R2 Product Yieldb (%)
1 H H 5a 90
2 H Me 5b 88
3 Br H 5c 85
4 4-Me–C6H4 H 5d 86
a The reactions were carried out with bis(indol-3-yl)sulﬁdes (4, 1.0 mmol) and
oxone (1.0 mmol), in 1:1 (v/v) H2O/acetone (5 mL), at room temperature for 4 h.




























Scheme 1. Synthesis of 3-substituted indole derivatives (3–5).
C. C. Silveira et al. / Tetrahedron Letters 54 (2013) 4926–4929 4927In order to explore the scope and limitations of the method, the
protocol was extended to other examples, under the optimized
conditions.10 The corresponding products were obtained in good
to excellent yields from different indoles (Table 1). The reaction
was also studied with the benzenesulfonothioate 2b (R3 = H), with
comparable success, albeit in slightly lower yields.
Taking into account our observation that higher temperatures
led to the formation of bis(indol-3-yl)sulﬁdes (4) and in view of
the importance of these compounds in general organic synthesis
as well as in materials science and in the pharmaceutical indus-
try,12 we decided to study further the above reaction.
When the reaction was carried out in DMA under microwave
irradiation (160 C), using Ce(III) as the promoter (1.0 mmol), in-
dole (2.0 mmol) and 2a (1.0 mmol), 53% of bis(indol-3-yl)sulﬁde
(4a)12e was obtained after 20 min, along with minor amounts of
the monosubstituted product 3a. However, when 2.0 equiv of
CeCl37H2O were employed, 4a was accessed in 89% yield (Table 2,
entry 1). Bis(indol-3-yl)sulﬁdes 4b–d were isolated in good yields
under the same conditions (Table 2), demonstrating that the trans-
formation is general.13
In view of the precedent of antioxidant activity among sulfone-
linked bis heterocycles,14 the bis(indol-3-yl)sulﬁdes 4 were
transformed into the corresponding sulfone derivatives 5.12e The
oxidation reaction was easily performed by treatment of 4a–dwith
oxone in a 1:1 (v/v) H2O/acetone medium, which smoothly
provided good yields of 5a–d (Table 3).15
In order to investigate the free radical scavenging ability of 3a
and 4a, the DPPH [di(phenyl)-(2,4,6-trinitrophenyl)imino azani-
um] and ABTS (2,20-azino-bis(3-ethyl benzothiazoline-6-sulfonic
acid) assays were used. Both are synthetic free radicals; however,
they sense different antioxidant mechanisms.Table 1





















Entry R1 R2 R3 Product Yielda (%)
1 H H Me 3a 98
2 H Me Me 3b 95
3 Br H Me 3c 87
4 4-Me–C6H4 H Me 3d 90
5 H H H 3e 92
6 H Me H 3f 90
7 Br H H 3g 86
8 4-Me–C6H4 H H 3h 86
a Isolated yield. All products were characterized by GC–MS, 1H and 13C NMR, and
elemental analysis.11DPPH has an unpaired electron which yields a strong absorption
maximum at 517 nm. It is now widely accepted that its reaction
with compounds like phenols proceeds through two different
mechanisms, including the direct hydrogen atom transfer (HAT)
and the sequential proton loss electron transfer.16 Thus, the un-
paired electron becomes paired in the presence of a free radical
scavenging antioxidant or hydrogen donor, decreasing the
absorption.16b
On the other hand, it was proposed that the reaction of indoles
with ABTS involves a single electron transfer process.16c
In the DPPH test,17 compounds 3a and 4a presented radical
scavenging at concentrations as low as 50 and 10 lM, respectively
(Table 4). The IC50 values (sample concentration required to inhibit
50% of the radicals) of 185.0 ± 39.7 (3a) and 22.5 ± 10.2 lM (4a)
and the maximum inhibition (Imax) results (76.5 ± 2.8% for 3a and
89.9 ± 2.5% for 4a) revealed that 4a is a more effective and more
potent DPPH radical scavenger.
In the ABTS assay performed, as disclosed by Re et al.18 the test
compounds were active at 5 lM levels (Table 4). When the IC50
(3a: 27.0 ± 24.2 lM; 4a: 3.6 ± 0.5 lM) and Imax results (3a:
99.7 ± 0.5%; 4a: 99.9 ± 0.005%) were compared, it was also con-
cluded that 4a is a more effective and more potent ABTS radical
scavenger.
On the other hand, lipid peroxidation involves a free radical
chain reaction. Radical scavengers may directly react with peroxide
radicals, quench their activity and terminate the peroxidation
chain reactions. In the linoleic acid peroxidation inhibition induced
Table 4
Antioxidant activity of compounds 3a and 4a in the ABTS, DPPH, FRAP, and linoleic acid peroxidation assays























Control — — — 0.20 ± 0.06 — — — 0.20 ± 0.06
1 10.9 ± 2.9 NT NT 0.25 ± 0.09 25.5 ± 13.5 NT NT 0.23 ± 0.09
5 25.8 ± 8.6⁄ NT NT 0.47 ± 0.22 68.4 ± 25.3 ⁄⁄⁄ 15.5 ± 23.3 6.8 ± 2.6 0.49 ± 0.24
10 38.1 ± 13.5⁄⁄ 15.3 ± 16.3 10.8 ± 5.6 0.75 ± 0.40 92.6 ± 5.2⁄⁄⁄ 38.6 ± 10.0 ⁄⁄⁄ 42.0 ± 9.1⁄⁄⁄ 0.76 ± 0.33⁄⁄⁄
50 77.4 ± 21.9⁄⁄⁄ 30.6 ± 15.7⁄ 19.5 ± 8.4⁄⁄ 1.59 ± 0.56⁄⁄⁄ 97.0 ± 3.4⁄⁄⁄ 79.8 ± 8.8⁄⁄⁄ 66.7 ± 3.7⁄⁄⁄ —
100 94.8 ± 5.8⁄⁄⁄ 42.1 ± 13.3⁄⁄ 58.2 ± 8.7⁄⁄⁄ — 96.8 ± 3.5⁄⁄⁄ 86.2 ± 6.7⁄⁄⁄ 95.6 ± 8.8⁄⁄⁄ —
500 — 78.3 ± 4.1⁄⁄⁄ 99.7 ± 0.6⁄⁄⁄ — — — — —
The asterisks denote p < 0.05 (⁄), p < 0.01 (⁄⁄) and p < 0.001 (⁄⁄⁄) as compared to the respective control sample (one-way ANOVA/Newman–Keuls).
IC50: concentration (lM) providing 50% inhibition in the assays; Imax: maximal inhibition (%); NT = no tested. Number of repetition = 5.
4928 C. C. Silveira et al. / Tetrahedron Letters 54 (2013) 4926–4929with Fe-ascorbic acid, carried out as reported by the group of
Choi,17 the symmetric sulﬁde 4a (IC50: 12.5 ± 0.3 lM) was also
more effective than its parent 3a (IC50: 85.5 ± 10 lM), although
both exhibited similar Imax values (3a: 99.7 ± 0.6%; 4a: 95.6 ± 8.8%).
The FRAP (ferric reducing antioxidant power) assay relates the
electron donation capability, which reﬂects the reducing power
of the test compound, with its antioxidant activity. When the test
was performed according to Stratil et al.19 indoles 3a and 4a
showed potential reducing power at concentrations of 50 and
10 lM, respectively, and above.
The structural requirements and mode of action of the in vivo
and in vitro antioxidant activity of polysubstituted indoles have
been the subject of several investigations.20 Although the exact
mechanism of action of these indole derivatives is still unknown,
a mechanistic picture can be drawn taking into account that many
naturally-occurring and synthetic indoles display antioxidant
activity, and the reactions of the antioxidant agent melatonin21
and related indoles with free radicals have been recently examined
through computational models,22 and that it has been shown that
melatonin exerts its biological activity as radical scavenger via a
nitrogen centered radical, the indolyl (or melatonyl) cation
radical.23
Accordingly, it can be proposed (Scheme 2) that compounds 3
and 4 interact with a free radical source (FR), through one of
two pathways, involving either single electron transfer (SET) or
hydrogen abstraction.24 In the ﬁrst case, electron transfer from
the antioxidant to the active radical would yield an anion (FR)
and a cation radical species like i. A structure resembling i has also
been proposed as an intermediate for the hypervalent iodine-med-
iated SET oxidation of indole derivatives.25 In the case if N-unsub-
























Scheme 2. Proposed mechanism for the antioxidant activity of the bis(indol-3-
yl)sulﬁdes (4).proton transfer from the cation radical to the anion, generating
species ii.
When the indolic nitrogen is unsubstituted, a direct transfer of
hydrogen between the antioxidant and the active radical may take
place, furnishing the corresponding nitrogen-centered indolyl rad-
ical (ii), which is the resonant form of iii.
The contribution of the C-3 substituent to the electronic density
of the indole nucleus may explain the differences in potency ob-
served between 3a and 4a. Increased activity due to a better stabil-
ization of the indole ring and delocalization of the electrons as a
consequence of the C-3 substitution has been also noticed recently
within the indole family.6
Conclusion
In summary, we have shown that CeCl37H2O is a very
convenient promoter for the reaction of indoles with aromatic
sulfonothioates, furnishing monosubstituted indoles 3 and
bis(indol-3-yl)sulﬁdes 4 under conventional heating or microwave
irradiation, respectively, both in excellent yields. The bis(indol-3-
yl)sulﬁdes were also converted into the very useful sulfones
derivatives 5 under very mild conditions. On the other hand, 3a
and 4a displayed antioxidant activity, bis(indol-3-yl)sulﬁde 4a
being a more potent antioxidant.
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